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ABSTRACT
Doorn, Derek R. Developing a Clinical Guideline with Embedded Algorithm for the
Dosing Frequency of Amoxicillin in Pediatric GABHS. Unpublished Doctor of
Nursing Practice capstone project, University of Northern Colorado, 2017.
Group A-beta hemolytic streptococcus (GABHS) pharyngitis, commonly called
“strep throat,” is a commonly seen diagnosis in primary care--most commonly seen in
individuals aged 5-15 years. Worldwide, 616 million estimated cases of GABHS
pharyngitis occur annually. Rheumatic heart disease, which might be a consequence of
GABHS pharyngitis, is estimated to cause about 6 million years of life lost annually. In
spite of the wide prevalence of the disease, in the current literature, there are differing
guidelines regarding treatment of GABHS pharyngitis, specifically with regard to the
dosing frequency of amoxicillin. Amoxicillin is a frequently recommended and utilized
drug in the treatment of GABHS pharyngitis, often chosen for its palatability and ease of
administration. Current literature shows increasing trends toward once daily dosing of
amoxicillin in the treatment of GABHS pharyngitis although twice daily dosing was and
is still widely utilized. This Doctor of Nursing Practice capstone project evaluated
whether a clinical algorithm with embedded algorithm utilizing current evidence-based
practice and expert opinions could improve provider proficiency in dosing as well as
improve patient outcomes and adherence.
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CHAPTER I

STATEMENT OF THE PROBLEM

Purpose/Background
Group A-beta hemolytic streptococcus (GABHS) pharyngitis, commonly called
“strep throat,” is estimated to cost between $224 million and $539 million annually in the
United States just for children and adolescents (Pfoh, Wessels, Goldmann, & Lee, 2008).
Over 616 million estimated cases of GABHS pharyngitis occur annually worldwide.
Rheumatic heart disease, which might be a consequence of GABHS pharyngitis, is
estimated to cause about six million years of life lost annually. Group A-beta hemolytic
streptococcus is one of the top 10 pathogens in estimated global mortality (Carapetis,
Steer, Mulholland, & Weber, 2005).
Group A-beta hemolytic streptococcus pharyngitis is most common in individuals
aged 5-15 years, although adults may also acquire the disease. Group A-beta hemolytic
streptococcus pharyngitis is very uncommon in children younger than three years with
the exception of children with risk factors such as an exposure to older children or
household contact with GABHS infection. Acute rheumatic fever (ARF) is also rare in
adults and children younger than three years of age (Alter, Vidwan, Sobande, Omoloja, &
Bennett, 2011).
While GABHS pharyngitis is self-limiting, complications such as otitis media,
peritonsillar abscess, and ARF are primary rationales noted for initiating antibiotic
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therapy (Shulman et al., 2012) in patients positively confirmed with GABHS pharyngitis
by either culture or rapid antigen detection testing. While penicillin V is the drug of
choice for non-allergic children with GABHS pharyngitis, amoxicillin has been shown to
be an acceptable alternative due to better palatability and reported better gastrointestinal
absorption (Curtin-Wirt et al., 2003). Palatability of amoxicillin is believed to improve
patient adherence, especially in children; adherence is known to decrease antibiotic
resistance among organisms. Palatability and ease of administration of antibiotics have
been shown to improve adherence in children (Baguley, Lim, Bevan, Pallet, & Faust,
2012).
Since 2006, two randomized clinical studies have been published, showing
amoxicillin administered once daily was non-inferior to dosing done twice daily in
GABHS pharyngitis (Clegg et al., 2006; Lennon, Farrell, Martin, & Stewart, 2008).
Current GABHS pharyngitis treatment guidelines continue to show differing opinions
between once daily and divided dosing of amoxicillin.
Problem Statement
Amoxicillin dosing guidelines for pediatric GABHS pharyngitis vary and are not
consistent with regard to dosing frequency. Current guidelines offer no direction or
clinical guidance based on patient presenting factors. This Doctor of Nursing Practice
(DNP) capstone project evaluated if a clinical guideline with embedded algorithm,
utilizing current evidence based practice and expert opinion, could improve provider
proficiency in dosing as well as improve patient outcomes and adherence.
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Gap Analysis
Primary care providers (PCPs) often dose amoxicillin for pediatric GABHS
pharyngitis twice daily. while patient adherence might be improved with once daily
dosing. However, daily dosing might be as effective as twice daily dosing and might
improve patient adherence. Practice guidelines are increasingly recommending once
daily dosing.
Banner Healthcare, Kaiser Permanente, UCHealth, Centura Healthcare,
HealthOne, and Kindred Healthcare are some of the largest healthcare systems in
Colorado. None of these entities have published guidelines online for GABHS
pharyngitis treatment or dosing frequency recommendations specific to the use of
amoxicillin for GABHS pharyngitis. While both daily and twice daily dosing regimens
have been shown to be effective, no current algorithms or guidelines have been published
detailing which populations might benefit from differences in dosing frequency.
Literature Review
A comprehensive search of internet resources including Cinahl, Google Scholar,
and The National Guideline Clearinghouse was performed using the terms pharyngitis,
streptococcal pharyngitis, evidence-based, group a beta hemolytic streptococcus,
tonsillitis, pharyngotonsillitis, amoxicillin, and pediatric. Dosing frequency
recommendations varied across guidelines and the literature, ranging from no
recommendation to once, twice, or three times daily dosing. Table 1 summarizes
recommended frequency of dosing from available current guidelines.
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Table 1
Current Guideline Recommendations
Clinical Guideline
Institute for Clinical Systems Improvement
(Snellman et al., 2013)

Dosing Recommendation
No Recommendation

Infectious Disease Society of America
(Shulman et al., 2012)

Once or Twice Daily

University of Michigan Health System
(2013)

Once Daily

National Institute for Health Care
Excellence (2012)

No Recommendation

American Heart Association (Gerber et al.,
2009)

Once Daily

UpToDate (Pichichero, 2017)

1, 2 or 3 Times Daily

Epocrates (2017)

Once or Twice Daily

Supporting Literature: Effectiveness
Fierro et al. (2014) found,
Significant variability in the diagnosis and treatment of pharyngitis exists across
and within pediatric practices, which cannot be explained by relevant clinical or
demographic factors. Our data support clinician-targeted interventions to improve
adherence to prescribing guidelines for this common condition. (p. 57)
In a 2006 randomized control study of 652 participants, Clegg et al. concluded,
Amoxicillin given once daily is not inferior to amoxicillin given twice daily.
Gastrointestinal and other events did not occur significantly more often in the
once-daily treatment group. From the data in this large, investigator-blinded,
controlled study, once-daily amoxicillin appears to be a suitable regimen for
treatment of GABHS pharyngitis. (p 761)
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Shvartzman, Tabenkin, Rosentzwaig, and Dolginov (1993) study found,
No difference was observed in the clinical response, days at work and school lost,
or residual positive cultures after two days. A significant difference in the
bacteriological response was found after 14 days with no positive cultures
observed in the amoxicillin group. These findings support the hypothesis that
amoxicillin once daily is as effective as phenoxymethylpenicillin (penicillin V) in
the treatment of group A beta hemolytic streptococcal pharyngitis. (p. 1172)
Feder, Gerber, Randolph, Stelmach, and Kaplan (1999) performed a 16-month
study of 152 children with GABHS pharyngitis between 4 and 18 years of age (mean was
9.9 years); 79 children were randomly assigned to receive once-daily amoxicillin and 73
were assigned to receive penicillin V three times a day. The children in the two treatment
groups were comparable with respect to age, duration of illness before initiation of
therapy, compliance, and signs and symptoms at presentation. No significant differences
were found in the clinical or bacteriologic responses of the patients in the two treatment
groups at the 18- to 24-hour follow-up visit. Bacteriologic treatment failures occurred in
4 (5%) of the 79 patients in the amoxicillin group and in 8 (11%) of the 73 patients in the
penicillin V group. These data demonstrated once-daily amoxicillin therapy was as
effective as penicillin V therapy given three times a day for the treatment of GABHS
pharyngitis.
Lennon et al. (2008) conducted a randomized non-inferiority trial in a schoolbased clinic in New Zealand. Children presenting with GABHS pharyngitis were
randomized to oral amoxicillin or oral penicillin V 500 mg twice daily for 10 days.
Eradication of GABHS was determined with follow-up throat cultures on days 3–6, 12–
16, and 26–36. Group A-beta hemolytic streptococcus isolates were serotyped to
distinguish bacteriological treatment failures (and relapses) from new acquisitions. Noninferiority was defined as an upper 95% confidence limit for the difference in success of
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eradication in the amoxicillin and penicillin V treatment groups. A total of 353 children
with positive throat swabs for GABHS were randomized to amoxicillin (n = 177) or
penicillin V (n = 176). The upper 95% confidence limit for the differences in positive
cultures between the antibiotics was 4.9% at days 3–6, 6.5% at days 12–16 and 8.5% at
days 26–36. Treatment failures (including relapses) occurred at each visit in 5.8%,
12.7%, and 10.7% of amoxicillin recipients and 6.2%, 11.9%, and 11.3% of penicillin V
recipients, respectively. No significant differences in resolution of symptoms were noted
between treatment groups. One case of unsubstantiated ARF occurred after seven days of
amoxicillin. It was concluded once-daily oral amoxicillin was not inferior to twice-daily
penicillin V for the treatment and eradication of GABHS in children with pharyngitis.
Supporting Literature: NonCompliance
Non-compliance is defined as “the extent to which the time history of the drug
administration corresponds to the drug regimen” (Urquhart, 1994, p. 203). Per Kardas
(2002), non-compliance with short-term antibiotic therapy for respiratory tract infections
is common. Medication non-compliance is associated with treatment failures,
deterioration of health, additional consultations, additional drugs, additional
hospitalizations, and increased costs of direct and indirect management.
One factor associated with non-compliance in antibiotic therapy is dosing
frequency. Sclar, Tartiglione, and Fine (1994) found the highest compliance with oncedaily dosing--as frequency of dosing increased, compliance decreased. Cockburn,
Gibberd, Reid, and Sanson-Fisher (1987) found increasing the number of doses to be
taken daily by one increased the probability of a patient being non-compliant by 72%.
Kardas (2007) showed overall compliance for once-daily dosing was 93.7% versus
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81.3% for twice daily dosing in antibiotic use for acute bacterial exacerbation of
bronchitis. A systematic review in 2015 by Falagas, Karagiannis, Nakouti, and Tansarli
found higher compliance among patients treated with once-daily dosing of antibiotics for
upper respiratory infections than for those receiving twice, thrice, or four-time daily
dosing.
Pharmacology of Amoxicillin
The method of action of amoxicillin is antibacterial. Orally administered doses
have a half-life of 61.3 minutes. Approximately 60% of an oral dose is excreted via the
kidneys within six to eight hours. Amoxicillin diffuses readily into most body tissues and
fluids with the exception of brain and spinal fluid and when meninges are inflamed. In
blood serum, amoxicillin is approximately 20% protein-bound (Drugs.com, 2017).
Summary
Group A-beta hemolytic streptococcus is a commonly occurring condition mostly
occurring among pediatric patients, affecting millions worldwide; if untreated, it can lead
to serious complications such as rheumatic heart disease as well as lost productivity and
increased healthcare costs. Amoxicillin is a common first line treatment in pediatric
GABHS pharyngitis. Although current guidelines vary in the frequency with which
amoxicillin should be prescribed, they are increasingly recommending once daily
administration.
Clinical presentation, risk of non-compliance, guideline preference, and other
factors might influence provider choice of frequency dosing. This DNP capstone project
evaluated if a clinical guideline with embedded algorithm utilizing current evidence
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based practice and expert opinion could improve provider proficiency in dosing as well
as improve patient outcomes and adherence.
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CHAPTER II
PROJECT DESCRIPTION
Project Objectives
This DNP capstone project had the following four primary objectives:
1.

Identify current amoxicillin dosing frequency patterns and trends for
pediatric GABHS in a clinical setting and ongoing review of current
literature.

2.

Develop and validate clinical guideline algorithm for pediatric GABHS
dosing frequency with a panel of experts.

3.

Implement the clinical guideline algorithm for pediatric GABHS dosing
frequencies.

4.

Assess provider satisfaction and patient outcomes post-implementation.
Congruence of Organizational Strategic
Plan to Project

The primary site for this project was the Holyoke Family Clinic, a frontier family
practice clinic. To reach a goal of 15 providers to survey, various rural and urban
providers were solicited to take part in the study. The U.S. Department of Agriculture
(USDA; 2015) classifies a community as frontier and rural based on low population size
and high geographic remoteness. The Banner Healthcare system is well established in
Colorado and has online resources detailing its strategic plans.
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The Banner Health Systems (2017) website identifies the organizations mission,
vision, and definition of innovations as follows:
•

Mission of Banner Health: “To make a difference in people's lives through
excellent patient care” (p. 1).

•

Vision of Banner Health: “We will be a national leader recognized for
clinical excellence and innovation, preferred for a highly coordinated patient
experience, and distinguished by the quality of our people” (p. 1).

Banner Health defines innovation as “the rapid identification and deployment of
strategies leveraging Banner’s operating model and the science of care delivery to ensure
an extraordinary patient experience, which is safe, efficient and effective" (p. 1).
Melissa Memorial Hospital (MMH) and Family Clinic is a site in a frontier region
of northeast Colorado; it is representative of frontier health care in Colorado. Melissa
Memorial Hospital is associated with Banner Healthcare but not a member of the Banner
system. In 2013, MMH conducted a community health needs assessment (see Appendix
A) that identified areas of developing new and enhancing existing community benefit
programs and services.
This project was consistent with that organization’s goals as it sought to utilize
existing evidence-based guidelines of care and expert opinions in developing a guideline
with embedded algorithm to address the dosing of amoxicillin in adolescent GABHS.
Some of the specific shared goals were those of clinical excellence and safe, efficient,
and effective care delivery.
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Theoretical Framework
This DNP capstone project utilized the Stetler (2001) model of evidence-based
practice, a well-recognized model used to “assess how research findings and other
relevant evidence can be applied in practice” (National Collaborating Centre for Methods
and Tools, 2011, p. 1), thus allowing research use to be linked with evidence-informed
practice. In this project, the outcome was to specifically translate the research regarding
amoxicillin dosing frequency into a guideline for practice in the family primary care
setting.
According to Stetler (1994), research use occurs in three forms. Instrumental use
refers to the concrete, direct application of knowledge. Conceptual use occurs when
using research changes the understanding or the way one thinks about an issue. Symbolic
or political/strategic use happens when information is used to justify or legitimate a
policy or decision or otherwise influence the thinking and behavior of others. These
different kinds of research use can occur together and be influenced by multiple factors at
the individual level.
The Stetler (2003) model outlines the following criteria to determine the
desirability and feasibility of applying a study or studies to address an issue:
•

Substantiating evidence;

•

Current practice (relates to the extent of need for change);

•

Fit of the substantiated evidence for the user group and settings; and

•

Feasibility of implementing the research findings (risk/benefit assessment,
availability of resources, stakeholder readiness).
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For this DNP capstone project, substantiating the evidence was done by
conducting an exhaustive literature search related to amoxicillin use in GABHS. After
project approval, a Statement of Mutual Agreement was signed by all committee
members (see Appendix B). Current practice was assessed at clinical settings that serve
pediatric populations by surveying individual providers in treatment preferences with
regard to use of amoxicillin for GABHS and by a review of the Holyoke Family Clinic
electronic medical records (EMRs). Emphasis was placed on variances in dosing
frequency, factors predisposing to non-compliance, or other characteristics that currently
influenced any dosing variance.
The fit of the substantiated evidence for the user group and settings was assessed
by multiple rounds of surveys utilizing the Delphi technique to establish consensus on
treatment regimens. Per the Rand Corporation (Helmer, 1967), developers of the
technique,
The Delphi method in its simplest form solicits the opinions of experts through a
series of carefully designed questionnaires interspersed with information and
opinion feedback. A convergence of opinion has been observed in the majority of
cases where the Delphi approach has been used. (Abstract)
The Delphi Method
The Delphi method is a technique used to establish a consensus decision from a
group. The initial questionnaire may collect qualitative comments that are fed back to the
participants in a quantitative form through a second questionnaire (Hasson, Keeney, &
McKenna, 2000). The results from the second round inform the questionnaire for the
third round; this process is repeated until consensus is achieved or until the number of
returns for each round decreases. A universally agreed proportion does not exist for the
Delphi as the level used depends upon sample numbers, aim of the research, and
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resources. Percentage of agreement ranges in the literature from 51% to 80% among
respondents. Feasibility of implementing the research findings was dependent on
reaching consensus and stakeholder readiness. The goal for participation in the Delphi
surveys was to solicit responses from a minimum of 15 providers.
Project Phases and Timelines
This project utilized the following four phases based on the Stetler (2001) model
of critical thinking and decision-making:
•

Phase I: Preparation

•

Phase II: Validation

•

Phase III: Comparative Evaluation/Decision Making

•

Phase IV: Translation/Application

Phase I was to identify the purpose of consulting evidence--to revise or establish
existing policy on amoxicillin dosing frequency for pediatric patients diagnosed with
GABHS pharyngitis based on current practice guidelines (December 2016 through May
2017).
Phase II was to assess current agency guidelines and existing evidence for
credibility, applicability, and adherence to best practice. Clinic charts were reviewed to
determine trends in dosing, cure rates, and returns to clinic for continued symptoms (May
2017 through August 2017).
Phase III was to organize and display all findings, utilize Delphi technique to
establish consensus, determine feasibility of implementation, choose to use findings,
gather more data, delay use, or reject depending on comparative evaluation (August 2017
through September 2017).
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Phase IV was to develop and implement an algorithm for dosing amoxicillin
dosing frequency based on expert opinions from the Delphi study and plan formal
dissemination/ change strategies (September 2017 through October 2017).
Resources
Resources for the implementation of this project were low cost. Personnel costs
were limited to time and travel for the project manager spent working on the project, time
of the site managers and primary care providers spent taking at least two surveys, and
reviewing existing facility guidelines and standards. Supply costs were limited to the
printing or emailing of at least two surveys sent to providers recruited to take part in the
expert panel. Technological resources included use of electronic medical records (EMR)
in use at the clinical site of choice for purposes of data collection and evaluation related
to project objectives.
Statement of Mutual Agreement
This author discussed the project with all committee members and with the
leadership staff at Holyoke Family Clinic including medical staff and clinic director; all
voiced support for the project (see Appendix B). The author has also maintained ongoing
communication with all involved parties. Project approval from the University of
Northern Colorado’s Institutional Review Board (IRB) was granted August 2017 after all
required documentation was completed (see Appendix C).
Summary
This DNP capstone project had four phases:
1.

Identify current amoxicillin dosing frequency patterns and trends for
Pediatric GABHS in a clinical setting.

15
2.

Develop and validate clinical guideline algorithm for pediatric GABHS
dosing frequency with a panel of experts.

3.

Implement the clinical guideline algorithm for pediatric GABHS dosing
frequencies.

4.

Assess provider satisfaction and patient outcomes post-implementation.

The chosen site was the Melissa Memorial Hospital and Family Clinic in frontier
northeastern Colorado. The Stetler (2001) model of evidence-based practice was utilized
as the framework for the study. Substantiating the evidence was done by conducting an
exhaustive literature search related to amoxicillin use in treating GABHS. Current
practice was assessed at various clinical settings that serve pediatric populations and by
surveying individual providers in treatment preferences. Emphasis was placed on
variances in dosing frequency, symptom presentation, or patient characteristics that
currently influenced any dosing variance. Timeline for the study was broken into phases
aligning with the Stetler model. Consensus was reached by using Delphi surveys for the
providers who agreed to take part.
Project resources were primarily limited to time of project supervisor, printing
and email costs for delivering surveys, provider time spent taking surveys, site manager
and staff time assisting with project as needed, and technological support from site IT
staff.
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CHAPTER III
EVALUATION PLAN
Methods
The design was a non-experimental field study utilizing Delphi surveys to obtain
consensus from a panel of experts in pediatric prescribing. Sample size was determined
by participation rates of PCPs at the study site and those solicited by email. The
population was comprised of PCPs identified by site manager and those consenting to
participate via email. Delphi questionnaires were administered either on paper or via
email to facilitate ease of use and participation.
Data Collection and Analysis
Data were collected via a Delphi method focused on building a guideline with
embedded algorithm for dosing frequency of amoxicillin for pediatric patients with
GABHS pharyngitis. A minimum of two rounds of questions was needed to determine
consensus and expert agreement with a goal of 70% concurrence. The study was done by
soliciting participation in online survey through SurveyMonkey sent to primary care
providers in northern Colorado. Data analysis was done by qualitative and quantitative
methods consistent with Delphi study techniques, and appropriate statistical analysis of
quantitative methods.
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Study Objectives
Objective One
The first objective was to identify current amoxicillin dosing frequency patterns
and trends for pediatric GABHS in a clinical setting and ongoing review of current
literature. To meet this objective, a retrospective chart review examining current dosing
guidelines, dosing frequency patterns, recurrence within four months, and trends utilized
by the clinic providers was studied and compared with the most recent guidelines from
the literature.
Consultation with the clinic pharmacist was done to ensure the most current
pharmacodynamics, pharmacokinetics, and excretion data for amoxicillin were available.
Providers were educated on the most recent guidelines via email. The clinic’s
Information Technologist was consulted regarding the use of the EMR system to obtain
data from the previous 12 months relating to GABHS pharyngitis specific dosing trends,
patterns, effectiveness, presenting symptoms, or other quantifiers influencing dosing.
These data were used to educate providers and formulate the initial round of Delphi
questionnaires.
Objective Two
The second objective was to develop and validate a clinical guideline algorithm
for pediatric GABHS dosing frequency with a panel of experts. To meet this objective,
PCPs were solicited via email to take part in online surveys utilizing the Delphi method
related to presenting symptoms, factors affecting compliance, and other patient
characteristics that might affect the frequency of dosing amoxicillin, current clinic trends,
and rationales for decisions made related to dosing frequency. The goal of consensus was
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initially set at 70% agreement to develop a clinical algorithm for amoxicillin dosing
frequency in pediatric patients diagnosed with GABHS pharyngitis. Survey questions are
lists are provided in Appendices D and E. Consent for participation was emailed with
each round of surveys (see Appendix F).
Objective Three
The third objective was to implement a clinical guideline with embedded
algorithm for pediatric GABHS dosing frequencies. To meet this objective, the guideline
was implemented upon approval from the clinical site (see Appendix B). To facilitate
ease of use, format was based on provider preference such as laminated cards.
Reminders were sent out via email or handout relating to guideline, algorithm, start date,
etc. Information Technology was consulted on the feasibility of alerts or other cues to be
placed in the EMR related to pediatric GABHS amoxicillin dosing frequencies.
A review of the guideline and embedded algorithm effectiveness was done within
90 days of implementation by review of charts, patient data, patient outcomes, and patient
phone surveys relating to satisfaction and compliance.
Objective Four
The fourth objective was to assess provider satisfaction and patient outcomes
post-implementation. To meet this objective, providers would be surveyed after
implementation as to satisfaction with guideline, effectiveness of guideline, and any
desired revisions to the guideline. This objective was not met due to time constraints of
the capstone project.
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Project Milestones
The timeline for completion of this project was as follows.
•

Idea approval from chairperson--January 2017.

•

Needs assessment--February 2017.

•

Final approval from committee--February 2017.

•

Defense of capstone proposal--May 2017.

•

Institutional Review Board approval--August 2017.

•

Electronic medical record review, evaluation of findings, and analysis of
data--August 2017.

•

Delphi surveys distributed--August-September 2017.

•

Guideline development and implementation plan--September 2017.
Summary

This capstone project was a non-experimental field study utilizing Delphi surveys
to obtain consensus from a panel of experts. Sample size was determined by
participation rates of PCPs at the study site and those solicited by email. Data were
collected via the Delphi method that focused on the building of a guideline with
embedded algorithm for the dosing frequency of amoxicillin for pediatric patients with
GABHS pharyngitis. Two rounds of questions were needed to determine consensus and
expert agreement with a goal of 70% concurrence. Data analysis was done by qualitative
and quantitative methods consistent with Delphi study techniques and appropriate
statistical analysis of quantitative methods.
To meet objective one--identifying current amoxicillin dosing frequency patterns
and trends for Pediatric GABHS in a clinical setting and ongoing review of current
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literature, a retrospective chart review examining current dosing guidelines, dosing
frequency patterns, recurrence within four months, and trends utilized by the clinic
providers was utilized; data were compared with the most current guidelines from the
literature.
To meet objective two--developing and validating a clinical guideline algorithm
for pediatric GABHS dosing frequency with a panel of experts via email, providers were
given a series of questionnaires utilizing the Delphi method related to presenting
symptoms, attributes, or other patient characteristics that might affect the frequency of
dosing amoxicillin, current clinic trends, and rationales for decisions made related to
dosing frequency.
To meet objective three--implementation of a clinical guideline with embedded
algorithm for pediatric GABHS dosing frequencies, the guideline would be implemented
pending approval from the clinical site. To facilitate ease of use, formats were based on
provider preference such as laminated cards. Reminders were sent out via email or
handout relating to guideline, algorithm, start date, etc.
To assess provider satisfaction and patient outcomes post-implementation,
providers would be surveyed after implementation regarding satisfaction with guideline,
effectiveness of guideline, and any desired revisions to the guideline.
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CHAPTER IV
RESULTS AND OUTCOMES
Project Outcomes
Objective One Outcomes
The first objective was to identify current amoxicillin dosing frequency patterns
and trends for pediatric GABHS in a clinical setting and ongoing review of current
literature. An EMR review of charts from Holyoke Family Clinic was performed for the
time period October 2015 to March 2017. Parameters of the search were patients aged 018 years with a diagnosis of GABHS pharyngitis. The review identified 25 patients with
a diagnosis of GABHS pharyngitis who received treatment with oral amoxicillin. Of the
25 patients treated with amoxicillin, 16 patients (64%) had orders for twice daily
treatment and nine patients (36%) had orders for once daily treatment.
Objective Two Outcomes
The second objective was to develop and validate a clinical guideline algorithm
for pediatric GABHS dosing frequency with a panel of experts. The author developed the
first and second round Delphi Study survey questions from evidence gathered during the
literature review, the EMR review of charts, and through knowledge of the population
and healthcare system. Round one survey answers informed the second round of survey
questions.
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Consent for participation was emailed with each round of surveys (see Appendix
F). Invitations to participate were emailed out in August and September 2017. Surveys
were available for 10 days. Survey questions for Delphi round one are available in
Appendix D and survey questions for Delphi round two are available in Appendix E.
Additionally, an algorithm for determining dosing frequency appropriateness (see
Appendix G) was made available for round two and participants were asked to rate the
algorithm for appropriateness. All panel experts invited to participate in round one were
invited to participate in round two regardless of their participation in round one. Survey
questions were made available on SurveyMonkey--an online platform for developing and
hosting surveys.
Participants for this DNP capstone project were experts chosen from providers
caring for family or pediatric patients in multiple northern Colorado settings. Nineteen
providers (10 physicians, 8 nurse practitioners, and 1 physician assistant) were invited to
participate in the surveys. Invitations were sent out via email with an embedded link to
the SurveyMonkey page where the survey could be accessed.
First round surveys garnered four responses for a 21% response rate. Second
round surveys garnered seven responses, for a 37% response rate. Responses were
confidential and data were shared with the project advisor for statistical evaluation.
Round one Delphi survey. Round one was available online from August 2 to
August 15, 2017. The first question asked, What is your current preferred treatment
approach toward pediatric patients with positive Group AB Hemolytic Strep (GABHS)
pharyngitis? All respondents (100%) identified antibiotics with 50% of respondents
specifically identifying amoxicillin.
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The second question asked: What guidelines (if any) do you currently utilize
related to pediatric GABHS pharyngitis treatment? Responses were “None,” “American
Academy of Pediatrics,” “Nurse practitioner protocols. Uphold and Graham,” and “Up To
Date and AAP.”
The third question asked: What is your current preference for dosing frequency of
amoxicillin for GABHS? All (100%) respondents identified twice daily dosing of
amoxicillin as the preferred frequency for pediatric GABHS pharyngitis.
The fourth question asked: What presenting symptoms, or other factors, might
influence your decisions related to dosing frequency? Factors identified as influencing
dosing frequency were identified as “None,” “Improve ease/compliance with dosing
schedule,” “None school or day,” and “Patient compliance, allergies.”
The fifth question asked: What factors do you believe contribute to pediatric noncompliance with antibiotic therapy? Factors identified were “Business of life,”
“Frequency & taste of medication,” “School or daycare with overlooking doses,” and
“Improved symptoms in two days so parents stop medication due to relief of symptoms.”
The sixth question asked: Would a more consistent and uniform amoxicillin
dosing regimen be helpful to your current group practice if that regimen was in line with
the most recent evidence based guidelines? Two respondents said “Yes” (50%), one said
“No” (25%), and one replied “Not sure” (25%) with the added comment of “only because
it is already prescript bid.”
Round two Delphi survey. Responses to the first survey questions were used to
build the survey questions for round two. Round two of the Delphi study received
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responses from seven providers. The survey was available online from August 24 to
September 5, 2017.
The first question asked: For pediatric patients with positive Group AB Hemolytic
Strep (GABHS) pharyngitis the preferred dosing frequency for amoxicillin is twice daily.
Do you agree? All seven respondents (100%) confirmed twice daily dosing as the
preferred dosing frequency for pediatric GABHS pharyngitis.
The second question asked: Patient compliance with antibiotics affects patient
outcomes in practice. Do you agree? Six of the seven (86%) respondents replied “Yes.”
The third question asked: Some of the primary factors affecting compliance with a
course of antibiotics include busy schedules, school or day care staff overseeing doses,
and multiple daily doses. All seven (100%) of respondents replied “Yes.”
The fourth question asked: For patients with factors that could affect compliance,
once daily dosing of amoxicillin is an alternative to help improve compliance. Do you
agree? Four (57%) respondents replied “Yes” and three (43%) respondents replied
“No.” The sole comment was from a provider who dissented saying, “Half-life too short
for once a day dosing.”
For the fifth question, a PDF file was attached in the survey (see Appendix F)
asking whether the four questions to ask (who, what, when, where) gave a good
indication of when variances to dosing might be warranted? All seven (100%)
respondents replied “Yes”. There were no negative responses to No. There are other
indicators, please list below.
The sixth question asked: For guidelines and algorithms such as this (see
Appendix F), what is the preferred format? Five of six (83%) respondents thought the
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preferred format was “3x5 laminated card, something small to post over a desk or work
area.” One of six (17%) respondents chose “Full printed page, easy to view.” One
respondent chose not to answer. There were no responses for the option of “Wallet sized
card, something easy to carry in my pocket, or to pin up” or “Other (please specify).”
Concurrences ranging from 57% to 100% in the second survey were within or
above the preset range deemed acceptable for this scholarly project. The Delphi
responses were utilized to create the guideline presented in Appendix H.
Objective Three Outcomes
The third objective was to implement a clinical guideline with embedded
algorithm for pediatric GABHS dosing frequencies. This project was divided into the
following four phases based on the Stetler (2001) critical thinking and decision-making
steps:
•

Phase 1: Identify the purpose of consulting evidence, which was to revise or
establish existing policy on amoxicillin dosing frequency for pediatric
patients diagnosed with GABHS pharyngitis based on current practice
guidelines. Currently, Holyoke Family Clinic has no established guideline
for amoxicillin dosing frequency. Current literature suggests a clinical
guideline with embedded algorithm utilizing current evidence-based practice
and expert opinions could improve provider proficiency in dosing as well as
improve patient outcomes and adherence.

•

Phase 2: Assessment. Current agency guidelines and existing evidence were
assessed for credibility, applicability, and adherence to best practice. The
review of the Holyoke Family clinic EMR showed preference for twice

26
daily dosing of amoxicillin for pediatric GABHS pharyngitis, which is
consistent with current clinical guidelines and best practice. As stated, no
current guidelines exist for amoxicillin dosing frequency.
•

Phase 3: Results. The Delphi technique was used to establish consensus
among a group of experts toward an algorithm for determining appropriate
factors, which might influence dosing frequency specifically related to risk
of non-compliance.

•

Phase 4: Develop and implement an algorithm for dosing amoxicillin dosing
frequency based on expert opinions from the Delphi study and plan formal
dissemination/change strategies. The plan for implementation of the
guideline with embedded algorithm would involve the involvement of all
stakeholders at the Holyoke Family Clinic for whom this guideline was
intended. Implementation at a small clinic would be to formally review the
proposed guideline at a scheduled meeting of providers. Pending revisions
and re-verifying preferred formats, a date would be set for formal
dissemination for a two- to four-week pilot/trial period. At the end of the
trial period, providers would be surveyed for their satisfaction with the
guideline and whether the guideline and algorithm achieved the stated
objectives. A phone survey of patients would also be conducted at that time
to assess patient satisfaction, treatment outcomes, and treatment compliance.
Following assessing data collected after the trial period, a decision would be
made by the stakeholders whether to continue using the guideline, restart
use after modifying the guideline, or to stop using the guideline altogether.

27
Following stakeholder approval, guideline would be physically
implemented.
Objective Four Outcomes
The fourth objective was to assess provider satisfaction and patient outcomes
post-implementation within 90 days of implementation by review of charts, patient data,
patient outcomes, and patient phone surveys relating to satisfaction and compliance;
patient satisfaction and outcomes would then be performed annually. Provider
satisfaction would also be reassessed within 90 days and annually to confirm its
effectiveness in meeting stated objectives. Information technology would be consulted
on the feasibility of placing reminders in the EMR to facilitate use of the algorithm and
assist with identifying treatment failures and successes.
Phase four was not completed during this capstone project. The guideline and
embedded algorithm will be available to Holyoke Family Clinic to implement if time and
resources allow.
Key Facilitators to Objectives
1.

Facilitators to the project included cooperation from all involved staff at
Holyoke Family Clinic, especially the IT department manager for assistance
with loading parameters, optimizing searches, and general support and
guidance with the facility EMR in determining dosing trends.

2.

All of the providers encountered at Holyoke Family clinic were likewise
supportive and generous with their time regarding any questions or
discussions regarding this project.
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3.

Capstone committee member Dr. Vicki Wilson generously supplied me with
a list family practice provider email addresses to invite to take part in this
study, greatly increasing the pool of experts who were likewise all very
generous with their time responding to survey questions.
Key Barriers to Objectives

1.

A barrier to any project is time and this project was no exception. Competing
demands from all involved as well as deadlines and logistics were a factor in
the scope and reach of this project.

2.

The author’s own limited experience with the Holyoke Family Clinic EMR
platform was a barrier but was largely mitigated by the outstanding support
from the clinic IT department.

3.

The timing of the project, while specifically related to GABHS pharyngitis,
largely took place during the summer months, which is historically when
GABHS pharyngitis diagnosis is at its nadir.

4.

Surveys were sent out during the month of August, which can be a
particularly busy time of year for many regarding time off from work and the
start of a new school year. This might have potentially affected survey
responses.
Unintended Consequences

Insight gathered from the study showed a universal preference to twice-daily
dosing with amoxicillin for GABHS, which was not surprising. However, there was less
support than expected for guidelines recommending once-daily dosing even though
current literature showed trends toward that. It would be interesting to see if once-daily
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dosing becomes more adopted in the future. Another trend identified in some online
resources was the utility of treatment versus nontreatment given the self-limiting nature
of GABHS and ongoing concerns of antibiotic resistant “superbugs.”
Another unintended consequence was a renewed appreciation for the scope of the
problems related with noncompliance--a recognized factor in efficient use of resources
and contribution to microbial antibiotic resistance.
Summary
A review of the Holyoke Family Clinic EMR revealed a pattern of twice-daily
dosing of amoxicillin for pediatric GABHS pharyngitis at a nearly two to one ratio as
opposed to once daily. Utilizing this evidence and the current literature, two rounds of
Delphi surveys were conducted using the SurveyMonkey online platform. Nineteen
Colorado providers were invited to take part. After two rounds of surveys, expert
consensus was reached and a guideline with embedded algorithm was developed. Plans
for implementing and evaluating the guideline specific to the Holyoke Family Clinic
were formulated.
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CHAPTER V
RECOMMENDATIONS AND IMPLICATIONS
FOR PRACTICE
The problem statement for this DNP capstone project was whether a clinical
guideline with embedded algorithm utilizing current evidence-based practice and expert
opinions could improve provider proficiency in dosing as well as improve patient
outcomes and adherence.
This project could be easily expanded to other medication frequencies and other
conditions, especially for pediatric patients where non-compliance might be an issue.
The four questions that made up the algorithm could also be adjusted with input from
stakeholders to be more reflective of a given practice’s clientele or population served.
If this project were to continue and be physically implemented, the evaluations
discussed in the implementation to be done within 90 days would be crucial in
determining if the implementation of the guideline was having a real-world effect on
improving patient outcomes and compliance as well as the practicality of the guideline
from provider and clinic standpoints.
For the author’s leadership goals, this project was enlightening regarding the
increased level of confidence with regard to evaluating current literature and seeking
input from other providers in relation to direct patient care concerns and practicality of
any implementations.
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Evaluation of Capstone Project
The American Association of Colleges of Nursing’s (AACN) stated goal for DNP
programs is to “produce nurses that are uniquely prepared to bridge the gap between the
discovery of new knowledge and the scholarship of translation, application, and
integration of this new knowledge in practice (Waldrop, Caruso, Fuchs, & Hypes, 2014,
p. 300). The DNP capstone project is the culmination of these qualities. The AACN
(2006) requires that DNP-prepared graduates complete a project that addresses complex
clinical issues and uses evidence to improve practice, process, or outcome. Practicefocused DNP graduates are prepared to generate new knowledge through innovation of
practice, translation of evidence, and implementation of quality improvement (AACN
2015).
Dennison, Payne, and Farrell (2012) described the final DNP project as “the
implementation of research or other evidence into practice” (p. 233). Absent from this
description were any guidelines as to project design or implementation. Nursing leaders
have called for building a culture of clinical scholarship to distinguish nurses who
graduate with a practice doctorate from a research doctorate (Mundinger, Starck,
Hathaway, Shaver, & Woods, 2009) but did not have a systematic approach for faculty to
evaluate if the final DNP project met AACN requirements for degree conferment. To this
end, a 5-point system of evaluation, known by the acronym EC as PIE, was developed by
Waldrop et al. (2014) to determine whether a DNP capstone project met the standards set
forth by the AACN. The five criteria of EC as PIE are E = enhances health outcomes, C
= culmination of practice inquiry, P = Partnerships with interdisciplinary teams, I =
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Implement/apply/translate evidence into practice, and E = Evaluation of practice
outcomes.
Enhances
This project enhanced health outcomes by improving provider proficiency in
dosing as well as improving patient outcomes and adherence. The development of a
practice guideline with embedded algorithm through use of expert opinion yielded a fourquestion algorithm that evaluates the primary factors influencing pediatric patient noncompliance with antibiotic regimens and created a tool providers might use to accurately
determine instances in which streamlining the dosing frequency might improve patient
adherence, lessen treatment failures, and improve patient outcomes.
Culminates
The culmination of practice inquiry was accomplished in this project by the
author identifying a topic during clinical rotations, performing an exhaustive literature
search, and identifying a gap in current practice. Through use of the Delphi method and
Stetler (2001) model, a practical and likely to be used practice guideline was developed.
A plan for implementation and evaluation was developed that could interface with
existing EMR at the Holyoke Family clinic as well as other settings in a timely and
reproducible fashion.
Partnerships
Collaboration with providers, clinic administration, IT, and patients was necessary
for this project. Delphi surveys were sent to physicians, physician assistants, and nurse
practitioners, representing a cross section of providers.
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Implements
Translating the evidence gathered from exhaustive literature searches formed the
backbone of this project. Communicating the evidence to and soliciting expert opinions
helped formulate the guideline this author developed. The author also crafted a plan for
implementation at the Holyoke Family Clinic.
Evaluates
Evaluation of the guideline with embedded algorithm developed during this
project was also planned. Provider satisfaction, preferred format, patient outcomes, and
EMR integration are all factors needing ongoing assessment and potential revisions and
refinement. Ongoing literature searches would also be necessary to stay abreast of any
new data relative to this topic.
Summary
This DNP capstone project could be easily expanded with input from
stakeholders. Upon potential physical implementation of this project, ongoing evaluation
would be crucial to ensure positive patient outcomes and provider satisfaction.
This Doctor of Nursing Practice capstone project met AANC standards (Waldrop
et al., 2014) by enhancing health outcomes, culminating practice inquiry, showing
partnerships with interdisciplinary teams, implementing/applying/translating current
evidence into practice, and evaluating practice outcomes.
The process of developing this project has been enlightening regarding the
author’s personal comfort level and confidence in his ability to discover new knowledge
and translate, apply, and integrate that new knowledge into practice.
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Identifying a gap in practice, finding supporting literature, and constructing a
Delphi study to achieve expert consensus on a clinical guideline that could identify
situations warranting alternative dosing frequencies for GABHS pharyngitis has been a
rewarding experience for the author. The developed guideline could easily be
implemented successfully into a practice setting as it has the potential to improve patient
outcomes.
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APPENDIX D
ROUND ONE DELPHI SURVEY
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1.

What is your current prescribing practice in regards to pediatric patients
diagnosed with GABHS Pharyngitis?

2.

What guidelines do you currently utilize related to pediatric GABHS Pharyngitis
treatment?

3.

How would you rate non-compliance with antibiotic regimens for pediatric clients
in your practice?
Choose one: Not A Problem, Minor Problem, Some Problems, Definite Problem.

4.

What factors do you believe contribute to pediatric non-compliance with
antibiotic therapy?

5.

Would a more consistent and uniform amoxicillin dosing regimen be helpful to
your current group practice, if that regimen was in line with the most recent
evidence based guidelines?
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APPENDIX E
ROUND TWO DELPHI SURVEY
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1. For pediatric patients with positive Group AB Hemolytic Strep (GABHS) pharyngitis the
preferred dosing frequency for amoxicillin is twice daily. Do you agree?
Yes

No

2. Patient compliance with antibiotics is an issue that affects patient outcomes in practice. Do
you agree?
Yes

No

3. Some of the primary factors affecting compliance with a course of antibiotics include busy
schedules, school or day care staff overseeing doses, and multiple daily doses. Do you agree?
Yes

No, there are other primary factors.

4. For patients with factors that cou affect compliance, once daily dosing of amoxicillin is an
alternative to help improve compliance. Do you agree?

Yes

No

5. For the PDF file attached in the survey invitation email, do the 4 questions to ask (who, what,
when, where) give a good indication of when variances to dosing might be warranted?
Yes

No. There are other indicators that should be addressed.

6. For guidelines and algorithms such as this one, what is the preferred format?
Wallet sized card, something easy to carry in my pocket, or to pin up.
3x5 laminated card, something small to post over a desk or work area.
Full printed page, easy to view.
Other (please specify)

60
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CONSENT FORM FOR HUMAN PARTICIPATION
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CONSENT FORM FOR HUMAN PARTICIPATION IN RESEARCH
UNIVERSITY OF NORTHERN COLORADO
HOLYOKE FAMILY CLINIC
Project title: Developing a Clinical Guideline with Embedded Algorithm
for the Dosing Frequency of Amoxicillin in Pediatric Group A-Beta Hemolytic
Streptococcus
Student Researcher: Derek Doorn, RN (DNP Student)
Research Advisor:
Kathleen N. Dunemn, PhD, APRN, CNM, School of
Nursing
Co-Advisor:
Vicki Wilson, PhD, MS, RN, School of Nursing
Committee Member: Jessica Skomp FNP.
Expert Consensus via a Delphi Study
Dear Provider,
I am developing a DNP Capstone project to evaluate if a clinical guideline with
embedded
algorithm, utilizing current evidence based practice and expert opinion, can
improve provider proficiency in dosing, and improve patient outcomes and
adherence. The primary goals of this project are:
1. Identify current amoxicillin dosing frequency patterns and trends for Pediatric
GABHS in a clinical setting, and ongoing review of current literature.
2. Develop and validate clinical guideline algorithm for Pediatric GABHS dosing
frequency with a panel of experts through use of the Delphi method.
3. Implement the clinical guideline algorithm for Pediatric GABHS dosing
frequencies.
4. Assess provider satisfaction and patient outcomes post-implementation.
The Delphi Method is a structured communication tool or technique that
utilizes a questionnaire format to survey a panel of experts (within the field of study
under investigation), using two or more rounds of questioning. Information gathered
from the Literature Review regarding amoxicillin dosing frequency in GABHS
Pharyngitis was used in development of the first round of questions. The first round of
questions will also relay general information regarding current recommendations from
multiple clinical guidelines in the diagnosis and treatment of GABHS Pharyngitis.
Responses gathered from at least two rounds of Delphi surveys will be used in
development of the clinical practice guideline. Planning how to implement the
recommendation as a clinical practice guideline and evaluate outcomes is the final phase
of this project.
The Delphi Method, originally developed in the 1950’s, has been used in
healthcare, as well as other industries and is of value when there is uncertainly or lack of
empirical knowledge to achieve general consensus. It is an effective tool to assist in
protocol changes as it requires integration of expert review and opinion even in the
presence of disagreement. It is anticipated that two rounds will be necessary for
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completion of this capstone project. All Delphi surveys will be sent and returned
electronically with a private e-mail account only accessible by the DNP student. It is
estimated that each participant will spend approximately 10-15 minutes in completion of
survey questions within each round of the Delphi process.
Delphi survey responses will be kept confidential, used only for sending surveys.
Participation is voluntary.
If you know any providers that may be interested in participating in these surveys,
please pass on or forward this email to them.
If you begin to participate, you may decide to stop or withdraw at any time. If
you have any questions, please contact one of the undersigned.
Having read the above document and having had an opportunity to ask any
questions, please access the link to Phase One: Delphi Study Round One Questions and
complete the survey.
If you complete the survey, it will be assumed that you have communicated
consent for your participation. You may keep this form for future reference. If you have
any concerns about your selection or treatment as a research participant, please contact
Sherry May, IRB Administrator, office of Sponsored Programs, Kepner, Hall, University
if Northern Colorado, Greeley, Co 80639. Phone 970-351-1910.
This informed consent will be e-mailed and accompany each round of the Delphi study
Student Researcher: Derek Doorn, BSN, RN, DNP-S
E-mail: door1075@bears.unco.edu
Phone: (720) 435-6205
Research Advisor: Kathleen N. Dunemn, PhD, APRN, CNM
E-mail: Kathleen.Dunemn@unco.edu
Phone: (970) 351-3081/ (303) 649-5581
Co-Research Advisor: Vicki Wilson, PhD, MS, RN
E-mail: Vicki.Wilson@unco.edu
Phone: (970) 351-1295
Committee Member: Jessica Skomp, FNP
Address: Holyoke Family Clinic, 1001 East Johnson St, Holyoke CO 80734
E-mail: jessica.skomp@bannerhealt.com
Phone: (303) 973-3529
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DOSING FREQUENCY ALGORITHM
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For Pediatric patients diagnosed with Group A Strep Pharyngitis, before deciding
on the frequency of dosing amoxicillin, ask these 4 questions.

WHO will be responsible for administering the medication?
If more than 1 person (i.e. parent, school nurse, day care staff)
consider once daily dosing.

WHAT will the patient tolerate regarding taste or multiple daily
dosing?
If not tolerant, consider once daily dosing.

WHEN would doses be administered?
If caregiver has a variable work/school/other schedule, consider
once daily dosing.

WHERE would doses be administered?
If doses would be administered in multiple locations (school, other
family, day care), consider once daily dosing.
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APPENDIX H
CLINICAL GUIDELINE WITH EMBEDDED ALGORITHM
FOR DOSING FREQUENCY OF AMOXICILLIN IN
PEDIATRIC GROUP A-BETA HEMOLYTIC
STREPTOCOCCAL PHARYNGITIS
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A Clinical Guideline with Embedded Algorithm for the Dosing
Frequency of Amoxicillin in Pediatric Group ABeta Hemolytic Streptococcal Pharyngitis.
Patient Population
Pediatric patients diagnosed with GABHS (Group A-Beta Hemolytic
Streptococcal) pharyngitis, who will be treated with amoxicillin.
Clinical Specialty
Family Practice
Infectious Diseases
Internal Medicine
Pediatrics
Intended Users
Advanced Practice Nurses
Nurses
Physician Assistants
Physicians
Objectives
•

Minimize duration of, and discomfort from, associated symptoms of GABHS.

•

Minimize treatment failures associated with medication non-compliance.

Key Points
•

In pediatric patients diagnosed with GABHS Pharyngitis, multiple factors can affect
compliance.

•

Twice daily Amoxicillin is the preferred treatment in pediatric GABHS Pharyngitis,
although once daily dosing has been shown to be as effective, and once daily dosing
has been shown to improve medication compliance compared to multiple daily
dosing.
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•

Patients at risk for non-compliance and associated treatment failure should be
identified and once-daily dosing may be considered for those patients identified as
at risk.

Background
Amoxicillin dosing guidelines for pediatric GABHS pharyngitis vary and are not
consistent with regards to dosing frequency. Current guidelines offer no direction or
clinical guidance based on patient presenting factors.
Recommendations
The strength of recommendation (I-III) and levels of evidence (A-D) are defined
at the end of the Recommendations field.
1. When treating pediatric patients diagnosed with GABHS pharyngitis with
amoxicillin, twice-daily dosing frequency is the preferred approach (I, D).
2. Use of a simple four question algorithm (see chart below) should be utilized for
patients deemed at risk for treatment failure related to non-compliance and to
determine appropriateness of using once-daily dosing frequency (I, D).

68
For Pediatric patients diagnosed with Group A Strep Pharyngitis, before deciding
on the frequency of dosing amoxicillin, ask these 4 questions.

WHO will be responsible for administering the medication?
If more than 1 person (i.e. parent, school nurse, day care staff)
consider once daily dosing.

WHAT will the patient tolerate regarding taste or multiple daily
dosing?
If not tolerant, consider once daily dosing.

WHEN would doses be administered?
If caregiver has a variable work/school/other schedule, consider
once daily dosing.

WHERE would doses be administered?
If doses would be administered in multiple locations (school, other
family, day care), consider once daily dosing.

Definitions
Levels of Evidence
A.
B.
C.
D.

Randomized controlled trials
Controlled trials, no randomization
Observational trials
Opinion of expert panel
Strength of Recommendation

I.
II.
III.

Generally should be performed
May be reasonable to perform
Generally should not be performed

Method Used to Formulate Recommendations
Expert Opinion
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Strategy for Obtaining Expert Opinion
Expert opinions were obtained by soliciting participation from 19 providers caring
for family or pediatric patients in multiple northern Colorado settings. Nineteen
providers (10 physicians, 8 nurse practitioners, and 1 physician assistant) were invited to
participate in the surveys. Invitations were sent out via email with an embedded link to a
SurveyMonkey page where the survey could be accessed.
Related National Guidelines
ICSI, IDSA, University of Michigan, NICE, AHA, UpToDate, and Epocrates
Guideline Developer
Derek Doorn DNP-S
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